Abstract: Methods and compositions for the treatment of treatment-resistant depression are described. More specifically, the invention demonstrates that intranasal administration of ketamine is effective to ameliorate the symptoms of depression in a patient who has not responded to an adequate trial of one antidepressant in the current episode and has recurrent or chronic depressive symptoms (>2 years).
Type:
Application
Filed:
March 5, 2014
Publication date:
September 11, 2014
Applicants:
Icahn School of Medicine at Mount Sinai, National Institute of Health, Yale University School of Medicine
Inventors:
Dennis S. Charney, Sanjay J. Mathew, Husseini K. Manji, Carlos A. Zarate, John H. Krystal
Abstract: Methods and compositions for the treatment of treatment-resistant depression are described. More specifically, the invention demonstrates that intranasal administration of ketamine is effective to ameliorate the symptoms of depression in a patient who has not responded to an adequate trial of one antidepressant in the current episode and has recurrent or chronic depressive symptoms (>2 years).
Type:
Application
Filed:
March 20, 2007
Publication date:
December 13, 2007
Applicants:
MOUNT SINAI SCHOOL OF MEDICINE, NATIONAL INSTITUTE OF HEALTH, YALE UNIVERSITY SCHOOL OF MEDICINE
Inventors:
Dennis Charney, Sanjay Mathew, Husseini Manji, Carlos Zarate, John Krystal
Abstract: TIRAP polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing TIRAP polypeptides and polynucleotides in therapy, and diagnostic assays for such.
Type:
Grant
Filed:
September 16, 2005
Date of Patent:
October 23, 2007
Assignee:
Yale University School of Medicine
Inventors:
Ruslan Medzhitov, Tiffany Horng, Gregory Barton
Abstract: TIRAP polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing TIRAP polypeptides and polynucleotides in therapy, and diagnostic assays for such.
Type:
Grant
Filed:
July 3, 2002
Date of Patent:
November 1, 2005
Assignee:
Yale University School of Medicine
Inventors:
Ruslan Medzhitov, Tiffany Horng, Gregory Barton
Abstract: The hNBC3 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing hNBC3 polypeptides and polynucleotides in therapy, and diagnostic assays for such.
Type:
Grant
Filed:
July 15, 1998
Date of Patent:
March 13, 2001
Assignees:
Yale University School of Medicine, SmithKline Beecham Corporation P.L.C., SmithKline Beecham Laboratories Pharmaceutiques
Inventors:
Walter F Boron, Antoine Michel Alain Bril, Nassirah Khandoudi, Xavier Martin, Steven Charles Jupe, Christopher John Rawlings, Trudy Rachel Doe
Abstract: HNBC1A polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing HNBC1A polypeptides and polynucleotides in the design of protocols for the treatment of ischemia heart disease, arrhythmia, congestive heart disease, stroke and renal failure, among others, and diagnostic assays for such conditions.
Type:
Grant
Filed:
August 19, 1998
Date of Patent:
August 1, 2000
Assignees:
SmithKline Beecham Laboratories, Pharmaceutiques and Yale University School of Medicine
Inventors:
Antoine Michel Alain Bril, Nassirah Khandoudi, Xavier Martin, Walter F Boron